Researcher.Life Logo

Drug Development Research : Impact Factor & More

eISSN: 1098-2299pISSN: 0272-4391

Key Metrics

CiteScore
5.2
H-Index
65
Impact Factor
< 5
SJR
Q2Drug Discovery
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Development Research

Drug Development Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Development Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Development Research

Title not available
  • 1 May 2026
  • Drug Development Research
FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
  • 1 May 2026
  • Drug development research
DPP4-Driven Ferroptosis Promotes Senescence: Galangin as a Therapeutic Agent for Age-Related Bone Loss.
  • 1 May 2026
  • Drug development research
Discovery of Tetrahydropyrrolo[3,4-c]pyrrole-1,3-dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore-Based Virtual Screening.
  • 27 Apr 2026
  • Drug development research
Secoisolariciresinol Diglucoside Alleviates LPS-Induced Acute Lung Injury by Inhibiting the NF-κB/NLRP3 Signaling Pathway.
  • 27 Apr 2026
  • Drug development research
Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple-Negative Breast Cancer Through Modulating HIF-1α/MMP-9 Pathway.
  • 27 Apr 2026
  • Drug development research
Title not available
  • 1 May 2026
  • Drug Development Research
FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
  • 1 May 2026
  • Drug development research
DPP4-Driven Ferroptosis Promotes Senescence: Galangin as a Therapeutic Agent for Age-Related Bone Loss.
  • 1 May 2026
  • Drug development research
Discovery of Tetrahydropyrrolo[3,4-c]pyrrole-1,3-dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore-Based Virtual Screening.
  • 27 Apr 2026
  • Drug development research
Secoisolariciresinol Diglucoside Alleviates LPS-Induced Acute Lung Injury by Inhibiting the NF-κB/NLRP3 Signaling Pathway.
  • 27 Apr 2026
  • Drug development research
Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple-Negative Breast Cancer Through Modulating HIF-1α/MMP-9 Pathway.
  • 27 Apr 2026
  • Drug development research

FAQs on Drug Development Research